- Home
- EVER vs RLAY Comparison
EVER vs RLAY Comparison
Compare EVER & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EVER
- RLAY
- Stock Information
- Founded
- EVER 2008
- RLAY 2015
- Country
- EVER United States
- RLAY United States
- Employees
- EVER N/A
- RLAY N/A
- Industry
- EVER Computer Software: Programming Data Processing
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- EVER Technology
- RLAY Health Care
- Exchange
- EVER Nasdaq
- RLAY Nasdaq
- Market Cap
- EVER 924.1M
- RLAY 1.0B
- IPO Year
- EVER 2018
- RLAY 2020
- Fundamental
- Price
- EVER $25.84
- RLAY $7.92
- Analyst Decision
- EVER Strong Buy
- RLAY Strong Buy
- Analyst Count
- EVER 4
- RLAY 9
- Target Price
- EVER $32.50
- RLAY $16.00
- AVG Volume (30 Days)
- EVER 544.2K
- RLAY 2.4M
- Earning Date
- EVER 11-03-2025
- RLAY 11-06-2025
- Dividend Yield
- EVER N/A
- RLAY N/A
- EPS Growth
- EVER 284.14
- RLAY N/A
- EPS
- EVER 1.44
- RLAY N/A
- Revenue
- EVER $644,656,000.00
- RLAY $8,355,000.00
- Revenue This Year
- EVER $32.27
- RLAY $27.30
- Revenue Next Year
- EVER $11.05
- RLAY $7.43
- P/E Ratio
- EVER $17.97
- RLAY N/A
- Revenue Growth
- EVER 57.83
- RLAY N/A
- 52 Week Low
- EVER $16.63
- RLAY $1.78
- 52 Week High
- EVER $30.03
- RLAY $8.36
- Technical
- Relative Strength Index (RSI)
- EVER 63.85
- RLAY 67.06
- Support Level
- EVER $23.04
- RLAY $6.28
- Resistance Level
- EVER $24.71
- RLAY $6.76
- Average True Range (ATR)
- EVER 1.01
- RLAY 0.53
- MACD
- EVER -0.01
- RLAY 0.11
- Stochastic Oscillator
- EVER 79.13
- RLAY 82.16
About EVER EverQuote Inc.
EverQuote Inc is engaged in the business activity of offering an online marketplace for insurance shopping, connecting consumers with insurance provider customers, which includes both carriers and agents. The online marketplace offers consumers to find relevant insurance quotes based on car insurance, home insurance, and life insurance. The platform of the company is driven by data science. The firm's data and technology platform match and connects consumers seeking to purchase insurance with relevant options from its broad direct network of insurance providers. It derives a majority of revenue from Direct channels.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).